3
Views
1
CrossRef citations to date
0
Altmetric
Articles

Haemoglobin level influences plasma brain natriuretic peptide concentration

, , , , , , & show all
Pages 527-531 | Received 16 Jun 2003, Accepted 26 Mar 2004, Published online: 23 May 2017

References

  • Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990; 323: 757–8.
  • Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82–91.
  • Yoshibayashi M, Kamiya T, Saito Y, Matsuo H. Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy. N Engl J Med 1993; 329: 433–4.
  • Matsumoto A, Hirata Y, Momomura S, Suzuki E, Yokoyama I, Sata M, Ohtani Y, Serizawa T. Effects of exer-cise on plasma level of brain natriuretic peptide in conges-tive heart failure with and without left ventricular dysfunc-tion. Am Heart J1995; 129: 139–45.
  • Tulevski, II, Groenink M, van Der Wall EE, van Veld-huisen DJ, Boomsma F, Stoker J, Hirsch A, Lemkes JS, Mulder BJ. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ven-tricular dysfunction. Heart 2001; 86: 27–30.
  • Yamamoto K, Burnett JC Jr., Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ven-tricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988–94.
  • Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, Sundsfjord JA, Dickstein K. Plasma brain natri-uretic peptide as an indicator of left ventricular systolic func-tion and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-ter-minal proatrial natriuretic peptide. Circulation 1996; 93: 1963–9.
  • Jourdain P, Bellorini M, Funck F, Fulla Y, Guillard N, Loiret J, Thebault B, Sadeg N, Desnos M. Short-term effects of sinus rhythm restoration in patients with lone atrial fib-rillation: a hormonal study. Eur J Heart Fail 2002; 4: 263–7.
  • Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A. The use of subcutaneous erythro-poietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737–44.
  • Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T, Steinbruch S. Shapira I, Laniado S, Iaina A. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcuta-neous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001; 37: 1775–80.
  • Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955–62.
  • Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart fail-ure. J Am Coll Cardiol 2002; 39: 1780–6.
  • Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor out-comes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223–5.
  • Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM. Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107: 226–9.
  • Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capac-ity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294–9.
  • Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230–6.
  • Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommenda-tions regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–83.
  • Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000; 102: 470–9.
  • Armstrong W, Feigenbaum H. Echocardiography. In: Braunwald E, ed. Heart Disease 6th ed. W.B. Saunders company, Philadelphia, 2001: 160–228.
  • SAS Institue Inc. the LIFEREG procedure SASISTAT User’s Guide Version 6, SAS Institute Inc, Cary, NC, 1990: 1024–5.
  • Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M. Attenua-tion of compensation of endogenous cardiac natriuretic pep-tide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circula-tion 1997; 96: 509–16.
  • de Lemos JA, Morrow DA, Bentley JH, Omland T, Saba-tine MS, McCabe CH, Hall C, Cannon CP, Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014–21.
  • Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126–30.
  • Hayashi R, Ogawa S, Watanabe Z, Yamamoto M. Cardio-vascular function before and after iron therapy by echocar-diography in patients with iron deficiency anemia. Pediatr Int 1999; 41:13–7.
  • San M, Demirta5 M, Burgut R, Birand A, Bagamigi F. Left ventricular systolic and diastolic functions in patients with sickle cell anemia. Int J Angiol 1998; 7: 185–7.
  • Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89: 745–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.